NYMX Nymox Pharmaceutical Corporation Stock Forecast Period (n+15) 22 Feb 2021


Stock Forecast


As of Sat Feb 20 2021 00:00:03 GMT+0000 (Coordinated Universal Time) shares of NYMX Nymox Pharmaceutical Corporation 0.94 percentage change in price since the previous day's close. Around 130068 of 77211000 changed hand on the market. The Stock opened at 3.18 with high and low of 3.17 and 3.33 respectively. The price/earnings ratio is: - and earning per share is -0.17. The stock quoted a 52 week high and low of 1.66 and 4.79 respectively.

BOSTON (AI Forecast Terminal) Mon, Feb 22, '21 AI Forecast today took the forecast actions: In the context of stock price realization of NYMX Nymox Pharmaceutical Corporation is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+15) for NYMX Nymox Pharmaceutical Corporation as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of NYMX Nymox Pharmaceutical Corporation as below:

NYMX Nymox Pharmaceutical Corporation Credit Rating Overview


We rerate NYMX Nymox Pharmaceutical Corporation because of derivatives receivables represent more than 3% of total assets for entities reporting under IFRS (or under local GAAP similar to IFRS for the accounting of derivatives) and are domiciled in countries for which our BICRA group is '1' to '4'. We use econometric methods for period (n+15) simulate with Bollinger Bands %B Wilcoxon Rank-Sum Test. Reference code is: 2623. Beta DRL value REG 38 Rational Demand Factor LD 6177.3516. To assess forecasted working capital outflows for companies with material intra-year working capital requirements (for example, companies in seasonal businesses), we use forecasted peak working capital outflows, per paragraph 32 of the liquidity criteria. For seasonal businesses, in many cases the annual projection might indicate a working capital inflow or neutral working capital, even though there could be material intra-quarter or inter-quarter outflows throughout the year. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for NYMX Nymox Pharmaceutical Corporation as below:
Frequently Asked QuestionsQ: What is NYMX Nymox Pharmaceutical Corporation stock symbol?
A: NYMX Nymox Pharmaceutical Corporation stock referred as NASDAQ:NYMX
Q: What is NYMX Nymox Pharmaceutical Corporation stock price?
A: On share of NYMX Nymox Pharmaceutical Corporation stock can currently be purchased for approximately 3.22
Q: Do analysts recommend investors buy shares of NYMX Nymox Pharmaceutical Corporation ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for NYMX Nymox Pharmaceutical Corporation at daily forecast section
Q: What is the earning per share of NYMX Nymox Pharmaceutical Corporation ?
A: The earning per share of NYMX Nymox Pharmaceutical Corporation is -0.17
Q: What is the market capitalization of NYMX Nymox Pharmaceutical Corporation ?
A: The market capitalization of NYMX Nymox Pharmaceutical Corporation is 248619422
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker, credit rating agency or route orders containing equities securities. In our Machine Learning experiment, we focus on an approach known as Decision making using game theory. We apply principles from game theory to model the relationships between rating actions, news, market signals and decision making.The rating information provided is for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. Usage as a credit rating or as a benchmark is not permitted.

301 Massachusetts Avenue Cambridge, MA 02139 667-253-1000 pr@ademcetinkaya.com